Declining Private Investment, Lack Of Innovation In New Antibiotic Research Threaten Efforts To Prevent Drug-Resistant Infections, WHO Says

U.N. News: Urgent need for ‘immediate’ solutions to combat drug-resistant infections, warns WHO
“Drug-resistant infections are on the rise as private investment in new antibiotic development declines, the World Health Organization (WHO) said on Friday. Two new WHO reports reveal that while some 50 new antibiotics and 10 biologics are under development, only 32 of the total target WHO-priority pathogens and the majority have very limited benefits when compared to existing antibiotics…” (1/17).

Additional coverage of the reports is available from Axios, DW, New York Times, and VOA.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.